Prognostic and clinicopathologic significance of the tumor–stroma ratio in pure endometrial serous carcinoma

To evaluate the association of stromal proportion with clinicopathological characteristics and survival outcomes in patients with pure endometrial serous carcinoma (ESC). This retrospective cohort study included 62 patients with pure ESC diagnosed between 2013 and 2025. Stromal proportion was assessed on hematoxylin–eosin-stained hysterectomy sections using a predefined 50% cutoff to classify tumors as stroma-low (≤ 50%) or stroma-high (> 50%). Overall survival (OS) and progression-free survival (PFS) were evaluated using Kaplan–Meier analysis and Cox proportional hazards regression. Of the 62 tumors, 43 (69.4%) were classified as stroma-low and 19 (30.6%) as stroma-high. High stromal proportion was significantly associated with advanced FIGO stage ( p = 0.003), lymphovascular space invasion ( p = 0.001), cervical stromal involvement ( p = 0.005), and pathological lymph node metastasis among surgically assessed patients ( p = 0.007). Patients with stroma-high tumors had shorter median OS (32.5 vs. 76.6 months; log-rank p = 0.018) and PFS (14.3 vs. 45.6 months; log-rank p = 0.003). In univariable Cox analysis, high stromal proportion was associated with poorer OS (HR = 2.266, 95% CI: 1.130–4.544; p = 0.021) and PFS (HR = 2.499, 95% CI: 1.314–4.751; p = 0.005). However, these associations were not significant after adjustment for FIGO stage and lymphovascular space invasion (OS: adjusted HR = 1.030, 95% CI: 0.502–2.115; p = 0.935; PFS: adjusted HR = 1.314, 95% CI: 0.653–2.645; p = 0.445). Advanced FIGO stage remained significantly associated with poorer PFS (adjusted HR = 2.755, 95% CI: 1.032–7.352; p = 0.043). High stromal proportion was associated with adverse clinicopathological characteristics and poorer unadjusted survival in pure ESC but was not an independent prognostic factor for OS or PFS. Larger studies using standardized stromal assessment methods are needed to clarify its potential clinical utility.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-11-13
DOI
https://doi.org/10.1186/s12885-026-17378-0
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prognostic and clinicopathologic significance of the tumor–stroma ratio in pure endometrial serous carcinoma

Mehmet Kefeli, Guzin Demirağ, Melih Akpunar, Ayşe Rumeysa Aydoğan Demir et al.
1 links
BMC Cancer
Endometrial and Cervical Cancer Treatments
article

Prognostic and clinicopathologic significance of the tumor–stroma ratio in pure endometrial serous carcinoma

Mehmet Kefeli, Guzin Demirağ, Melih Akpunar, Ayşe Rumeysa Aydoğan Demir, Teyfik Demir, Zafer Kiraz
article en

Abstract

To evaluate the association of stromal proportion with clinicopathological characteristics and survival outcomes in patients with pure endometrial serous carcinoma (ESC). This retrospective cohort study included 62 patients with pure ESC diagnosed between 2013 and 2025. Stromal proportion was assessed on hematoxylin–eosin-stained hysterectomy sections using a predefined 50% cutoff to classify tumors as stroma-low (≤ 50%) or stroma-high (> 50%). Overall survival (OS) and progression-free survival (PFS) were evaluated using Kaplan–Meier analysis and Cox proportional hazards regression. Of the 62 tumors, 43 (69.4%) were classified as stroma-low and 19 (30.6%) as stroma-high. High stromal proportion was significantly associated with advanced FIGO stage ( p = 0.003), lymphovascular space invasion ( p = 0.001), cervical stromal involvement ( p = 0.005), and pathological lymph node metastasis among surgically assessed patients ( p = 0.007). Patients with stroma-high tumors had shorter median OS (32.5 vs. 76.6 months; log-rank p = 0.018) and PFS (14.3 vs. 45.6 months; log-rank p = 0.003). In univariable Cox analysis, high stromal proportion was associated with poorer OS (HR = 2.266, 95% CI: 1.130–4.544; p = 0.021) and PFS (HR = 2.499, 95% CI: 1.314–4.751; p = 0.005). However, these associations were not significant after adjustment for FIGO stage and lymphovascular space invasion (OS: adjusted HR = 1.030, 95% CI: 0.502–2.115; p = 0.935; PFS: adjusted HR = 1.314, 95% CI: 0.653–2.645; p = 0.445). Advanced FIGO stage remained significantly associated with poorer PFS (adjusted HR = 2.755, 95% CI: 1.032–7.352; p = 0.043). High stromal proportion was associated with adverse clinicopathological characteristics and poorer unadjusted survival in pure ESC but was not an independent prognostic factor for OS or PFS. Larger studies using standardized stromal assessment methods are needed to clarify its potential clinical utility.

BMC Cancer
Ondokuz Mayıs University (TR)
Good health and well-being
Endometrial and Cervical Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon